We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Safety monitoring and information (121)
- Compliance and enforcement (32)
- Import and export (28)
- Shortages and supply disruptions (17)
- Sunscreens (7)
- Advertising (6)
- COVID-19 (5)
- Labelling and packaging (4)
- Weight loss products (4)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
475 result(s) found, displaying 401 to 425
-
-
Safety alerts
-
Safety alertsWe are advising that Movectro (cladribine) has been withdrawn from supply in Australia due to commercial reasons.
-
Safety alerts
-
Safety alerts
-
Safety alertsWe are reviewing the safety of the Pneumovax 23 vaccine due to reports of severe local reactions and have updated our revaccination recommendations.
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Market actionsWe are recalling Thelin (sitaxentan) worldwide due to serious liver risks. Consult your doctor if you have concerns.
-
Safety alertsSeasonal flu vaccine: Response to the West Australian (Stokes) Review
-
Market actions
-
Safety alertsDo not use So Hard for Men tablets, Shaguar tablets, and Pulse8 for Women capsules as they contain undeclared tadalafil and are not approved. Consult your doctor if you have concerns.
-
Market actionsWeight loss drug Sibutramine (Reductil) withdrawn in Australia due to heart risks.
-
Safety alertsWe are analysing the safety of the Panvax H1N1 vaccine following reports of febrile convulsions in children.
-
Safety alertsWe are investigating febrile reactions in young children following the 2010 flu vaccine and have paused its use for kids under 5 in Western Australia.
-
Safety alerts
-
Market actionsPanvax Junior is being recalled because of a drop in potency, and all available stocks are being removed.
-
Safety alerts
-
Safety alertsConsumers are advised to stop using Hydroxycut products due to serious adverse reactions, including liver toxicity. We highlight differences between US and Australian formulations and recommend caution. Consult your doctor if concerned.